OBP-401-GFP telomerase-dependent adenovirus illuminates and kills high-metastatic more effectively than low-metastatic triple-negative breast cancer in vitro.

导出原文传递

翻译打印收藏纠错

第一作者： S,Yano

第一单位： AntiCancer, Inc., San Diego, CA, USA.;Department of Surgery, University of California San Diego, CA, USA.;Department of Gastroenterological Surgery, Okayama University, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan.

作者： S,Yano ^[1] ; K,Takehara ^[1] ; H,Kishimoto ^[2] ; H,Tazawa ^[3] ; Y,Urata ^[4] ; S,Kagawa ^[2] ; M,Bouvet ^[5] ; T,Fujiwara ^[2] ; R M,Hoffman ^[6]

作者单位： AntiCancer, Inc., San Diego, CA, USA.;Department of Surgery, University of California San Diego, CA, USA.;Department of Gastroenterological Surgery, Okayama University, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan. ^[1] Department of Gastroenterological Surgery, Okayama University, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan. ^[2] Center for Innovative Clinical Medicine, Okayama University Hospital, Okayama, Japan. ^[3] Oncolys BioPharm Inc., Tokyo, Japan. ^[4] Department of Surgery, University of California San Diego, CA, USA. ^[5] AntiCancer, Inc., San Diego, CA, USA.;Department of Surgery, University of California San Diego, CA, USA. ^[6]